P Trivedi

Author PubWeight™ 45.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Laparoscopic kidney transplantation: an initial experience. Am J Transplant 2011 2.24
2 Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993 2.09
3 Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988 2.01
4 Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 1998 1.94
5 Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum 1996 1.85
6 Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992 1.81
7 Asymptomatic spontaneous rupture of suprasellar dermoid cyst: a case report. Neurol India 2002 1.73
8 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 1994 1.59
9 Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A 2000 1.42
10 Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol 1993 1.37
11 Inhibition of glucose 6-phosphatase by pure and impure C-type phospholipases. Reactivation by phospholipid dispersions and protection by serum albumin. Biochem J 1975 1.15
12 Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c. Biochem Biophys Res Commun 1994 1.12
13 Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001 1.06
14 Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. Leukemia 2012 1.02
15 Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene 2009 0.98
16 Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells. J Exp Med 1998 0.98
17 HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis 2013 0.96
18 Intraparticle surface diffusion of metal contaminants and their attenuation in microporous amorphous Al, Fe, and Mn oxides. J Colloid Interface Sci 2002 0.91
19 Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 1992 0.90
20 Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India. Indian J Cancer 2011 0.86
21 Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Eur J Immunol 1990 0.86
22 Dendritic cell differentiation blocked by primary effusion lymphoma-released factors is partially restored by inhibition of P38 MAPK. Int J Immunopathol Pharmacol 2011 0.86
23 Systemic bone changes accompanying early rheumatoid arthritis in patients treated with nonsteroidal antiinflammatory drugs alone. Clin Orthop Relat Res 1994 0.85
24 Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques. J Virol 1999 0.84
25 A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene. J Immunol 1999 0.83
26 Lipoadenoma of the parathyroid gland - a rare cause of hyperparathyroidism. Gulf J Oncolog 2012 0.83
27 Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res 2000 0.82
28 Serum hyaluronic acid as an early prognostic marker in biliary atresia. J Pediatr Surg 2001 0.81
29 Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest 1985 0.81
30 Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. Int J Cancer 1992 0.81
31 Serum type III procollagen peptide as a non-invasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and alpha 1 antitrypsin deficiency. Clin Chim Acta 1986 0.80
32 Transformation-associated Epstein-Barr virus antigens as targets for immune attack. Ann N Y Acad Sci 1993 0.80
33 Validation of a simple radiochemical assay measuring hydrolysis of choline-labelled microsomal phosphatidylcholine by phospholipase C. pH-dependence. Biochem J 1976 0.79
34 Developmental changes in the intra-acinar distribution of succinate dehydrogenase, glutamate dehydrogenase, glucose-6-phosphatase, and NADPH dehydrogenase in the rat liver. J Pediatr Gastroenterol Nutr 1989 0.79
35 Developmental regulation of phosphoprotein gene expression in the caudate-putamen of rat: an in situ hybridization study. Neuroscience 1992 0.79
36 Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. J Med Virol 1998 0.79
37 The application of quantitative cytochemistry to study the acinar distribution of enzymatic activities in human liver biopsy sections. J Hepatol 1989 0.77
38 Carbon tetrachloride-induced hepatic fibrosis and cirrhosis in the developing rat: an experimental model of cirrhosis in childhood. Br J Exp Pathol 1983 0.77
39 Optimizing multimodality treatment for head and neck cancer in rural India. Indian J Cancer 2012 0.76
40 QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase. Bioorg Med Chem Lett 2006 0.76
41 Effect of rectal distension on voluntary external anal sphincter function in healthy subjects. Colorectal Dis 2011 0.76
42 Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Mol Immunol 1993 0.76
43 Serum concentrations of extracellular matrix components: novel markers of metabolic control and hepatic pathology in glycogen storage disease? J Pediatr Gastroenterol Nutr 1991 0.75
44 Dextrans--potential polymeric drug carriers for suprofen. Pharmazie 2003 0.75
45 Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus. Leukemia 2005 0.75
46 Molecular modeling and 3D-QSAR studies in 2-aziridinyl-and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as potential antimalarial agents. SAR QSAR Environ Res 2001 0.75
47 QSAR study on hetaryl imidazoles: a novel dual inhibitor of VEGF receptors I and II. Med Chem 2010 0.75
48 Hepatic peptidyl prolyl hydroxylase activity and liver fibrosis--a prospective study of 94 infants and children with hepatobiliary disorders. Hepatology 1984 0.75
49 Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins. J Gen Virol 1997 0.75
50 Pili bigeminy induced by low fluence therapy with hair removal alexandrite and ruby lasers. Dermatol Surg 1999 0.75
51 QSAR study on N-(aryl)-4-(azolylethyl) thiazole-5-carboxamides: novel potent inhibitors of VEGF receptors I and II. Med Chem 2009 0.75
52 Extensive malakoplakia of the nasopharynx: management of a rare disease. J Oral Maxillofac Surg 1998 0.75
53 Adaptative changes of metabolic zonation during the development of cirrhosis in growing rats. Gastroenterology 1990 0.75
54 Mental health. Partners, not adversaries. Nurs Times 1996 0.75
55 Dextrans--potential polymeric drug carriers for flurbiprofen. Pharmazie 2003 0.75
56 Anterior retropharyngeal approach to the cervical spine. Neurol India 2001 0.75
57 Is there a link between breast cancer and abortion: a review of the literature. Int J Fertil Womens Med 2006 0.75
58 A case study: application of statistical process control tool for determining process capability and sigma level. PDA J Pharm Sci Technol 2012 0.75